Neuroscience and Neuropharmacology Research
Neuroscience and Neuropharmacology Research is a research topic within Cellular and Molecular Neuroscience. Science Explorer counts 146k research works in it since 1950. 20.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the molecular mechanisms underlying synaptic plasticity, focusing on neurotransmission, GABAergic and glutamatergic systems, neuronal circuits, astrocyte function, NMDA receptors, dendritic spines, and long-term potentiation. The research also investigates the relevance of these mechanisms to neurological disorders.
- Synaptic Plasticity
- Neurotransmission
- GABAergic
- Glutamate Receptors
- Neuronal Circuits
- Astrocyte Function
- NMDA Receptors
- Dendritic Spines
- Long-Term Potentiation
- Neurological Disorders
- Research works
- 146k fractional, since 1950
- In the world top 10%
- 30k per year above
- Top-10% rate
- 20.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -9% the tick is no change
Which countries lead Neuroscience and Neuropharmacology Research research?
By volume, the United States and China publish the most (3.1k and 1.6k works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.1k works
- 2 China 1.6k works
- 3 Japan 563 works
- 4 Germany 557 works
- 5 United Kingdom 415 works
- 6 Russia 403 works
- 7 Canada 369 works
- 8 France 344 works
- 9 India 341 works
- 10 Italy 339 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Neuroscience and Neuropharmacology Research research?
By volume in 2022–2025, Yale University publishes the most Neuroscience and Neuropharmacology Research research, followed by University College London and Harvard University.
By volume, 2022–2025
- 1 Yale UniversityUnited States 55 works
- 2 University College LondonUnited Kingdom 54 works
- 3 Harvard UniversityUnited States 50 works
- 4 InsermFrance 45 works
- 5 University of PittsburghUnited States 44 works
- 6 Institute of Evolutionary Physiology and BiochemistryRussia 43 works
- 7 Centre National de la Recherche ScientifiqueFrance 41 works
- 8 University of TorontoCanada 40 works
- 9 Columbia UniversityUnited States 37 works
- 10 University of California, IrvineUnited States 36 works
Who are the leading researchers in Neuroscience and Neuropharmacology Research?
The most-cited researchers publishing on Neuroscience and Neuropharmacology Research include Félix Carvalho and Guido Kroemer.
- 1 Félix Carvalho Portugal 4.6k citations
- 2 Guido Kroemer France 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Neuroscience and Neuropharmacology Research research done?
The largest centres of Neuroscience and Neuropharmacology Research research in 2022–2025 are Beijing (China), Paris (France), London (United Kingdom) and Moscow (Russia). Among places with at least 20 works in it, it is an unusually large share of all research in Pushchino.
Largest cities, 2022–2025
Where it is the local speciality
- PushchinoRU · 20.9 works26×
Location quotient: how much more of its research is in Neuroscience and Neuropharmacology Research than the world average.
Where is the best place to study Neuroscience and Neuropharmacology Research?
Among universities, judged by research, Harvard University, Center for Excellence in Brain Science and Intelligence Technology and Brandeis University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 55.6 | 37.9% | 3.9× | 50 | -17.3% |
| 2 | Center for Excellence in Brain Science and Intelligence TechnologyChina | 53.0 | 30.8% | 44.7× | 9 | — |
| 3 | Brandeis UniversityUnited States | 52.3 | 37.1% | 12.9× | 11 | -21.9% |
| 4 | Weizmann Institute of ScienceIsrael | 52.0 | 37.9% | 8.0× | 12 | -21.4% |
| 5 | Yale UniversityUnited States | 51.8 | 24.5% | 5.3× | 55 | -3.6% |
| 6 | Columbia UniversityUnited States | 51.5 | 38.2% | 4.3× | 37 | -26.6% |
| 7 | Okinawa Institute of Science and Technology Graduate UniversityJapan | 50.5 | 22.2% | 19.4× | 10 | +5.1% |
| 8 | University College LondonUnited Kingdom | 49.7 | 24.3% | 3.8× | 54 | -16.3% |
| 9 | University of Colorado Anschutz Medical CampusUnited States | 49.1 | 25.6% | 7.5× | 21 | +28.9% |
| 10 | University of California, IrvineUnited States | 48.6 | 26.5% | 6.0× | 36 | -23.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Neuroscience and Neuropharmacology Research research growing?
Output in 2018–2022 was 9% lower than in 2013–2017, peaking in 2008.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.